Nuwellis, Inc. To Announce Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023 16:15 ET
|
Nuwellis, Inc.
MINNEAPOLIS, July 18, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that its...
Nuwellis Inc. Announces Pilot Agreement With DaVita Inc.
June 20, 2023 08:30 ET
|
Nuwellis, Inc.
MINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has...
Nuwellis to Participate in the Maxim Group Virtual Healthcare Conference
June 13, 2023 16:15 ET
|
Nuwellis, Inc.
MINNEAPOLIS, June 13, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that...
Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors
June 05, 2023 16:15 ET
|
Nuwellis, Inc.
MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of patients suffering from fluid overload, today...
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2023 17:10 ET
|
Nuwellis, Inc.
MINNEAPOLIS, May 22, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that, effective May 19, 2023, the Company’s independent directors approved equity awards under Nuwellis’...
Nuwellis, Inc. Announces First Quarter 2023 Financial Results
May 09, 2023 08:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...
Nuwellis, Inc. To Announce First Quarter 2023 Financial Results on May 9, 2023
April 18, 2023 08:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, April 18, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that its...
Nuwellis Announces Peer-Reviewed Publication of Clinical Trials Analysis Advocating the Use of Ultrafiltration for Heart Failure Patients Resistant to Diuretics
March 21, 2023 08:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the...
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2023 08:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, March 01, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), today announced that, effective February 23, 2023, the Company’s independent directors approved equity awards under...
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023 08:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...